Evidence map›Paper›PMID 30676831›Full record

ReviewExpert opinion on drug discovery2019

Inkjet dispensing technologies: recent advances for novel drug discovery.

Sina Azizi Machekposhti, Saeid Mohaved, Roger J Narayan

Abstract readReview
In one paragraph

Review in Expert opinion on drug discovery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Extrusion bioprinting: meeting the promise of human tissue biofabrication?Progress in biomedical engineering (Bristol, England) · 2025
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Utilization of 3D printing technology in hepatopancreatobiliary surgery.Journal of Zhejiang University. Science. B · 2024
    Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Chemical Screening of Nuclear Receptor Modulators.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sina Azizi Machekposhtia Department of Mechanical Engineering , K. N. Toosi University of Technology , Tehran , Iran.
Saeid Mohavedb Joint Department of Biomedical Engineering , University of North Carolina and North Carolina State University , Raleigh , NC , USA.
Roger J Narayanb Joint Department of Biomedical Engineering , University of North Carolina and North Carolina State University , Raleigh , NC , USA.

Funding

Biodegradable Microneedle-Based Transdermal Treatment of Cutaneous LeishmaniasisR21AI117748 · NIAID · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI NARAYAN, ROGER J, WERBOVETZ, KARL A · 2016 to 2017
$413k
Microneedles for emergency treatment of synthetic opioid overdoseR21DA040916 · NIDA · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI NARAYAN, ROGER J · 2018 to 2019
$374k
NIAID NIH HHS R21 AI117748NIDA NIH HHS R21 DA040916
6 · The paper itself

Abstract

introductionInkjet-dispensing printing is a promising additive manufacturing method for pharmaceutical applications such as drug discovery. The unique advantages of this technology, including low cost, programmability, high resolution, high throughput, high speed, and biocompatibility, may reduce the financial resources needed to discover new drug candidates. Sophisticated and miniaturized assays have been developed to accomplish drug discovery and drug screening using modern inkjet dispensing printers. Areas covered: This paper reviews recent advancements in the field of inkjet printer technology for drug discovery. Various types of inkjet printers and their recent use for the drug discovery are summarized; physical and biological limitations of this technology are also examined. Furthermore, typical inks used in the inkjet printing technology are introduced. Expert opinion: Inkjet bioprinting technology is a promising tool for many biological and pharmaceutical applications. Several bottlenecks associated with this technology need to be addressed before commercialization. For example, sophisticated inks need to be synthesized to meet both biological and engineering restrictions. Further progress of parallel technologies will enhance the performance and functionality of the printers. It is also worth emphasizing that inkjet printing technologies must meet the requirement of regulatory agencies (e.g. the US Food & Drug Administration) for commercialization by the pharmaceutical industry.

Indexed as

Printing, Three-DimensionalAnimalsDrug DiscoveryDrug IndustryHumansPharmaceutical PreparationsTechnology, PharmaceuticalPharmaceutical Preparationsdrug discoverydrug screeninginkInkjet dispensing technologyinkjet printer

Identifiers

PMID30676831
PMCPMC10357954

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.